STML
Stemline Therapeutics, Inc.
STML
STML
Delisted
STML was delisted on the 9th of June, 2020.
99 hedge funds and large institutions have $449M invested in Stemline Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 46 increasing their positions, 20 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 100 → 99 (-1)
50% less call options, than puts
Call options by funds: $314K | Put options by funds: $631K
Holders
99
Holding in Top 10
2
Calls
$314K
Puts
$631K
Top Buyers
| 1 | +$9.75M | |
| 2 | +$7.58M | |
| 3 | +$3.99M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$3.67M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$2.92M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$12.6M | |
| 3 | -$5.79M | |
| 4 |
JGC
J. Goldman & Co
New York
|
-$4.05M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$2.82M |